SHANGHAI - Swiss pharmaceutical giant Roche has announced plans to invest 2.04 billion yuan ($283 million) in building a new ...

British Airways is ordering 32 new long-haul aircraft from Boeing in a deal worth nearly $13 billion, the airline's parent ...

Unfortunately, biotech has been in a brutal run of its own: ...

A live audio webcast of the fireside chat will also be available to the general public and can be accessed at ...

Gyre Therapeutics ("Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced financial results for the first quarter ended March 31, 2025 ...

To stay ahead, Hong Kong focuses on talent acquisition and retention. The Research Talent Hub under the Innovation and ...

[Photo provided to chinadaily.com.cn] Hong Kong-listed Shanghai Henlius Biotech Inc ... Since the inception of the company in 2010, its six products have been launched in China, four have been ...

Chinese banks, brokerages and private equity firms are among companies kicking off plans on Thursday to sell so-called ...

BeiGene aims to be a next-generation oncology innovator by broadening its drug and pipeline portfolio to various solid tumors in addition to blood cancers. As such, it been actively investing to build ...

The U.S. claims China engages in unfair trade practices, although Beijing has increasingly shown its commitment to the world ...

IN BRIEFUS Patent Office granted Active Biotech's patent application for laquinimod in eye disorders (January 28)Active Biotech announced that the first patient was enrolled in the European ...

Keytruda is set to lose exclusivity in 2028, meaning Summit may face competition from cheaper biosimilars. Meanwhile, other ...